SCNX Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 2.39%, SMA50 -8.66%, SMA200 -52.29%). The stock’s 14-day RSI is 49.02 (neutral), while the ATR of 0.04 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -87.66% below its high and over 19.78% above its low. Average 10-day trading volume of 227.34 thousand shares is below the 3-month average of 3.13 million, indicating normal recent market interest.

Scienture Holdings, Inc. has 16.13 million shares outstanding. The public float is 12.57 million shares, elevated short interest at 0.45% of float. This equals 46.93 thousand shares. The short ratio is 0.2 days. Institutional investors hold 4.76% of the float. Insiders own 21.88%.

Scienture Holdings, Inc. generated EPS of -$1.81 over the past year. Five-year average earnings growth is -50.13%. Wall Street analysts project EPS growth of 41.68% annually over the next five years. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 1 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $1.50 to $1.50. The high target offers 265.85% upside. The low target suggests 265.85% downside. The mean target is $1.50. This offers 265.85% upside. Scienture Holdings, Inc. earnings surprise history is a mixed track record. The quarter that ended May 11, 2026, missed forecasts by -65.22%. The prior quarter beat by 700.0%. Over the last six quarters, Apple has recorded several small beats. These include 4166.67% in June 26, 2024.

Scienture Holdings, Inc. last paid a dividend of 1.5 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.89. This means the shares are trading below this model’s fair value.

Our AI price prediction model suggests that Scienture Holdings, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -0.73%, with price expected at $0.41 by June 11, 2026, within a range of $0.40 to $0.43 3-Month Outlook: Projected rise of 270.46%, reaching $1.53 by August 26, 2026, with a range of $1.42 to $1.64. 1-Year Outlook: Projected gain of 1076.76%, with price at $4.86 by May 28, 2027, within a range of $4.49 to $5.40.

Scienture Holdings, Inc. (NASDAQ:SCNX) shares are flat -2.71% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Scienture Holdings, Inc. trading at a premium to the broader market with a P/E of -4.03. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $1.50, suggesting 263.2% upside. Our AI forecast model points to short-term weakness (-0.73% over two weeks), a medium-term rise (270.46% over three months), and a longer-term gain (1076.76% over one year), with expected trading ranges indicating moderate volatility.

Scienture Holdings, Inc. (NASDAQ:SCNX) closed at $0.41 USD, losing -$0.01 (-1.41%) from the previous close of $0.42. The stock is currently mid-range between its 52-week high and low $0.24 and $2.60. With a market capitalization of about $6.37 million, Scienture Holdings, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~3.17). Key stats such as the average daily volume over the past year has been around 2.99 million shares, volume is running light vs its 52-week average. Headquartered in Tampa, FL, Scienture Holdings, Inc. operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Shankar Hariharan, the company employs approximately 14 people and listed since February 06, 2014. TRxADE HEALTH, Inc. operates as health services IT company.

Scienture Holdings, Inc. trades at a P/E ratio of -4.03, slightly below the S&P 500 average, with a price-to-sales ratio of 13.4 The P/FCF stands at -0.0, also above market averages.